Zeteo Biomedical LLC News - Profile and Newsroom at Send2Press Newswire

Zeteo Biomedical LLC Newsroom - Profile and News Archive

Zeteo Biomedical(tm) is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications.

Engage with Zeteo Biomedical LLC

Follow:

Press Releases from Zeteo Biomedical LLC :

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals

Mar 10, 2021 6:00 AM EST

AUSTIN, Texas, March 10, 2021 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent 10238577). This latest patent expands the capabilities of Zeteo’s ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

Nov 17, 2020 6:01 AM EST

AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.